Cells were treated with vehicle or drugs in 96-well black-walled clear-bottom plates. After treatment, the CellTiter-Blue reagent (Promega) was added and plates were further incubated for 3 h before the cell viability was measured as mentioned above. The Caspase-Glo® 3/7 Reagent (Promega) was then added in each well and cells were further incubated for 1 h. Luminescence was then measured as per the manufacturer’s instructions. The caspase-3/7 activities were normalized to the cell viability and expressed as the percentages relative to the vehicle control of each cell line.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.